CDC COCA Call: Recommendations for Pfizer-BioNTech and Moderna COVID-19 Vaccine Primary Series in Children 6 Months through 5 Years Old
|
|
While children have a lower risk for severe COVID-19 compared to adults, they can get COVID-19, spread it to others, and become seriously ill. COVID-19 vaccination provides protection to children and adolescents against severe illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death.
During this COCA Call, presenters will discuss CDC’s new guidance on the pediatric COVID-19 vaccine primary series for children ages 6 months through 4 years old for Pfizer-BioNTech and ages 6 months through 5 years old for Moderna, including children who are moderately or severely immunocompromised.
If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.
The slide set will be available on the day of the call on the COCA Call webpage under Call Materials.
Free Continuing Education (CE) will be offered for this COCA Call.
Registration is not required.
Call Information
Date: Wednesday, June 22, 2022
Time: 1:00 PM – 2:00 PM CT (2:00 PM – 3:00 PM ET)
A few minutes before the webinar starts, please click on the Zoom link below to join:
https://www.zoomgov.com/j/1613205078
Passcode: 533156
|
